Wird geladen...

The Use of Genomics to Drive Kidney Disease Drug Discovery and Development

As opposed to diseases such as cancer, autoimmune disease, and diabetes, identifying drugs to treat CKD has proven significantly more challenging. Over the past 2 decades, new potential therapeutic targets have been identified as genetically altered proteins involved in rare monogenetic kidney disea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin J Am Soc Nephrol
Hauptverfasser: Reilly, Dermot F., Breyer, Matthew D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Nephrology 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7480559/
https://ncbi.nlm.nih.gov/pubmed/32193173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11070919
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!